Gert van der Hoek
In Memoriam - Editor, Senior Moderator
Summary, google translated
Guillain-barre syndrome and new influenza A (H1N1) virus
Bart C. Jacobs, Leonoor Wijnans, Miriam Sturkenboom and Nicoline van der Maas
The coming weeks one third of the Dutch population will be vaccinated against new influenza A (H1N1).
In 1976, during a U.S. vaccination campaign against a similar virus, increases of Guillain-Barr? syndrome (GBS) of about 1 patient per 100,000 vaccinees.
Subsequent research into influenza vaccine showed no or a much lower risk of GBS.
GBS can also occur after infections, including influenza A. The risk of GBS following influenza vaccination is probably much lower than the risk of GBS following influenza infection.
It is unknown whether vaccination or infection with the new influenza A (H1N1) virus can induce GBS. The very low rate of GBS can only be determined during the vaccination campaign.
In the Netherlands, several measures taken to monitor these risks during the vaccination campaign.
http://www.ntvg.nl/publicatie/guillain-barr-syndroom-en-het-nieuwe-in/volledig
Full article, via Google translation:
http://translate.google.com/transla...ieuwe-in/volledig&sl=nl&tl=en&history_state0=
Guillain-barre syndrome and new influenza A (H1N1) virus
Bart C. Jacobs, Leonoor Wijnans, Miriam Sturkenboom and Nicoline van der Maas
The coming weeks one third of the Dutch population will be vaccinated against new influenza A (H1N1).
In 1976, during a U.S. vaccination campaign against a similar virus, increases of Guillain-Barr? syndrome (GBS) of about 1 patient per 100,000 vaccinees.
Subsequent research into influenza vaccine showed no or a much lower risk of GBS.
GBS can also occur after infections, including influenza A. The risk of GBS following influenza vaccination is probably much lower than the risk of GBS following influenza infection.
It is unknown whether vaccination or infection with the new influenza A (H1N1) virus can induce GBS. The very low rate of GBS can only be determined during the vaccination campaign.
In the Netherlands, several measures taken to monitor these risks during the vaccination campaign.
http://www.ntvg.nl/publicatie/guillain-barr-syndroom-en-het-nieuwe-in/volledig
Full article, via Google translation:
http://translate.google.com/transla...ieuwe-in/volledig&sl=nl&tl=en&history_state0=